| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |